Juno Therapeutics Backtesting

Juno Therapeutics Inc -- USA Stock  

USD 86.56  0.08  0.0923%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Juno Therapeutics Inc and determine expected loss or profit from investing in Juno Therapeutics over given investment horizon. Please also check Juno Therapeutics Hype Analysis, Juno Therapeutics Correlation, Juno Therapeutics Valuation, Juno Therapeutics Volatility as well as analyze Juno Therapeutics Alpha and Beta and Juno Therapeutics Performance
 Time Horizon     30 Days    Login   to change

Juno Therapeutics 'What if' Analysis

January 24, 2018
No Change 0.00  0.0%
In 31 days
February 23, 2018
If you would invest  0.00  in Juno Therapeutics on January 24, 2018 and sell it all today you would earn a total of 0.00 from holding Juno Therapeutics Inc or generate 0.0% return on investment in Juno Therapeutics over 30 days. Juno Therapeutics is related to or competes with NantKwest, Del Mar, Denali Therapeutics, VBI Vaccines, and Vascular Biogenics. Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies

Juno Therapeutics Upside/Downside Indicators


Juno Therapeutics Market Premium Indicators

Juno Therapeutics Inc lagged returns against current returns

 Current and Lagged Values 

Juno Therapeutics regressed lagged prices vs. current prices

 Current vs Lagged Prices 

Juno Therapeutics Inc Backtested Returns

We consider Juno Therapeutics not too risky. Juno Therapeutics Inc holds Efficiency (Sharpe) Ratio of 0.0878 which attests that Juno Therapeutics Inc had 0.0878% of return per unit of risk over the last 1 month. Our philosophy towards determining volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Juno Therapeutics Inc which you can use to evaluate future volatility of the corporation. Please check out Juno Therapeutics Downside Deviation of 0.2401, Market Risk Adjusted Performance of 0.65 and Risk Adjusted Performance of 0.11 to validate if risk estimate we provide are consistent with the epected return of 0.0423%. Juno Therapeutics has performance score of 5 on a scale of 0 to 100. The company retains Market Volatility (i.e. Beta) of -0.0427 which attests that as returns on market increase, returns on owning Juno Therapeutics are expected to decrease at a much smaller rate. During bear market, Juno Therapeutics is likely to outperform the market.. Although it is extremely important to respect Juno Therapeutics Inc current price history, it is better to be realistic regarding the information on equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By evaluating Juno Therapeutics Inc technical indicators you can presently evaluate if the expected return of 0.0423% will be sustainable into the future. Juno Therapeutics Inc right now retains a risk of 0.4813%. Please check out Juno Therapeutics Maximum Drawdown as well as the relationship between Expected Short fall and Rate Of Daily Change to decide if Juno Therapeutics will be following its current trending patterns.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.13 

Insignificant predictability

Juno Therapeutics Inc has insignificant predictability. Overlapping area represents the amount of predictability between Juno Therapeutics time series from January 24, 2018 to February 8, 2018 and February 8, 2018 to February 23, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Juno Therapeutics Inc price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Juno Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient 0.13
Spearman Rank Test -0.07
Price Variance 0.29
Lagged Price Variance 0.01

Juno Therapeutics Lagged Returns

 Regressed Prices 

Juno Therapeutics Performance vs DOW

The median price of Juno Therapeutics for the period between Wed, Jan 24, 2018 and Fri, Feb 23, 2018 is 85.75 with a coefficient of variation of 0.43. The daily time series for the period is distributed with a sample standard deviation of 0.37, arithmetic mean of 85.75, and mean deviation of 0.24. The Stock received some media coverage during the period.
Price Growth (%)  
Reliable Long-term Trend to Profit From Juno Therapeutics, I...02/22/2018